Publications by authors named "A Aleyasin"
Article Synopsis
- Poor ovarian response (POR) affects women over 35 with low ovarian reserve, making it hard to achieve live births; this study tests astaxanthin as a treatment to improve outcomes.
- 60 POR patients underwent a trial, receiving either astaxanthin or a placebo while monitoring various oxidative stress and inflammation markers.
- Results showed that the astaxanthin group had better serum antioxidant levels and lower inflammatory markers, though no main differences were found in follicular fluid; this suggests astaxanthin might help with ovarian response in ART.
Polycystic ovarian syndrome (PCOS) is related to pro-apoptotic and pro-inflammatory conditions generated by Endoplasmic reticulum (ER) stress. This study aimed to determine the effect of Astaxanthin (ASX), as carotenoid with potent antioxidant and anti-inflammatory properties, on serum inflammatory markers, apoptotic factors and ER stress-apoptotic genes in peripheral blood mononuclear cells (PBMCs) of women with PCOS. This randomized, double-blind clinical trial included 56 PCOS patients aged 18-40.
View Article and Find Full Text PDFObjective: Astaxanthin (ASX) is a lipid-soluble keto-carotenoid with several biological effects. These effects may benefit polycystic ovarian syndrome (PCOS) patients. Imbalanced apoptosis/anti-apoptosis signaling has been considered the major pathogenesis of PCOS.
View Article and Find Full Text PDFArticle Synopsis
- - This study presents a Delphi consensus from seven Iranian infertility experts focusing on the role of luteinizing hormone (LH) in assisted reproductive technology (ART), aiming to fill a gap in regional consensus documents related to LH supplementation.
- - The consensus process involved three steps: an initial approval of eight statements, a vote by a 20-member panel, and a revision of one statement that initially lacked agreement, which then achieved an 83% consensus after modification.
- - The findings emphasize the importance of incorporating expert clinical perspectives into guidelines, particularly to enhance treatment outcomes for patients with deficiencies in follicle-stimulating hormone (FSH) and LH.
Objective: The purpose of this study was to examine the recurrence rates of ovarian endometrioma, dysmenorrhea, dyspareunia, and related complications between sclerotherapy and laparoscopic ovarian cystectomy in individuals aged 25 to 38.
Methods: Eighty-eight women participated in this retrospective, single-center study between January 2020 and February 2022. Patients received either laparoscopy or sclerotherapy, depending on the opinion of the pertinent physician.